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The effect of risk and race on lower extremity
amputations among Medicare diabetic patients
Joshua B. Goldberg, MD,a Philip P. Goodney, MD, MS,b,c Jack L. Cronenwett, MD,b and
Frank Baker, PhD,d Lebanon and Hanover, NH; and Valhalla, NY
Objective: The effect of national quality initiatives aiming at limiting lower extremity amputations in diabetic patients
remains uncertain. We therefore explored trends in amputation among Medicare diabetic patients with a focus on those
at highest risk.
Methods: The Diabetes Analytical File, an enhanced sample of all diabetic patients from the Medicare 5% sample, was used
to study the national incidence of amputation in diabetic patients. Within a cohort of 5 million diabetic patients
between 1999 and 2006, we compared the incidence of amputation in high-risk (end-stage renal disease or more than
three comorbidities) and low-risk groups and by race.
Results: Between 1999 and 2006, 23,976 amputations were performed, comprising 11,558 in high-risk and 12,418 in
low-risk patients. The amputation rate declined over time from 4.8/1000 in 1999 to 4.4/1000 in 2006 (P < .001).
High-risk patients represented a growing proportion of all amputations (33% in 1999, 50% in 2006; P < .001) despite
representing 4% of diabetic patients in 1999 and 10% in 2006 (P < .001). The incidence of amputation was 29.6/1000
in the high-risk group vs 2.7/1000 in low-risk patients (P< .001). African Americans had higher rates of amputation in
high-risk and low-risk groups.
Conclusions:High-risk patients represent a minority ofMedicare diabetic patients but account for 50% of all amputations,
and this effect is magnified in African Americans. Future quality improvement efforts should focus on high-risk patients
and African Americans. ( J Vasc Surg 2012;56:1663-8.)
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fDiabetes is a growing epidemic in the Medicare popu-
lation.1 Among the numerous complications associated
with poorly controlled diabetes, lower extremity amputa-
tions represent one of the most morbid adverse outcomes.2
Accordingly, several payer- and provider-based initiatives
have published management guidelines aimed at prevent-
ing amputation as well as other adverse sequelae of diabe-
tes.3-6 Specifically, Healthy People 2010, an ongoing
health improvement effort maintained by the Centers for
Disease Control and Prevention (CDC) and the National
Institutes of Health (NIH), provides numerous recom-
mendations toward improving the care of diabetic patients.
On the basis of their estimates of the economic and societal
effect of amputations secondary to diabetes, the CDC and
NIH set forth a specific goal of decreasing the number of
amputations among diabetic individuals by 55% during a
10-year period.4
Despite such ambitious goals, the real-world effective-
ness of national guidelines and quality improvement initia-
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http://dx.doi.org/10.1016/j.jvs.2012.05.100ives to decrease the incidence of amputations among dia-
etic patients remains uncertain, because initiatives similar
o Healthy People 2010 instituted in other countries have
ot resulted in convincing improvement in amputation.
or example, England established similar recommenda-
ions and goals as Healthy People 2010 in 1999. An
nalysis of a large administrative database of 50,000
ontraumatic amputations in England demonstrated an
ncrease in the burden of amputations on the diabetic
opulation after initiation of management recommenda-
ions.7 In The Netherlands, data on amputation rates after
nitiation of diabetes quality improvement initiatives also
emonstrated little effect.8
Within the U.S., although many have lauded attempts
o improve diabetic care with quality improvement initia-
ives, whether they have resulted in any real effect on
mputations among diabetic individuals remains unknown.
herefore, to assess the effect of Healthy People 2010 on
he incidence of lower extremity amputations among dia-
etic individuals, we analyzed trends in the incidence of
ower extremity amputation among the Medicare diabetic
opulation in recent years.
ETHODS
Data set description. We used the Diabetes Analytic
ile (DAF), an enhanced administrative data source, for our
nalysis. The Centers for Medicare and Medicaid Services
CMS) created the Chronic Condition Warehouse DAF to
ompile data on diabetic patients within the Medicare
ystem. The DAF contains a wide array of beneficiary data
rom fee-for-service and non–fee-for-service participants as
ell as institutional and noninstitutional claims (Fig 1).9 All
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the database if they have a diagnosis of diabetes according
to a validated algorithm.9,10 In brief, the diagnostic algo-
rithm requires patients to have at least one inpatient or two
outpatient claims for diabetes during a 2-year period ac-
cording to International Classification of Disease-9th Clin-
ical Modification diagnostic codes 250.00 93, 357.2,
362.01 02, and 366.41.
The enhanced 5% DAF differs from the traditional 5%
sample because the enhanced 5%DAF keeps a patient in the
database over subsequent years. In the traditional 5% sam-
ple, patients may be present inMedicare claims in 1 year but
be dropped from the data set in another year because of
insufficient claims. In contrast, a patient who reaches the
criteria for inclusion into the DAF is never dropped from
the database. This expanded database permits more robust
longitudinal analysis of elderly diabetic patients, regardless
of their longitudinal connection to Medicare.
Cohort formation. Our cohort consisted of benefi-
ciaries aged 50 years who underwent lower extremity
amputation between 1999 and 2006 (the most recent years
available). Basic demographic information was gathered,
including age, sex, and race. As coded in the data set, lower
extremity amputations were defined as major and minor
amputations, including toe, below-knee, and above-knee
amputations. The database lists lower extremity amputa-
tion as a single categoric variable for a given year, which
includes all major and minor amputations (International
Classification of Disease-9th Clinical Modification proce-
dural codes 84.10-17). Beneficiary comorbidities are de-
fined by the CMS Chronic Condition convention.9 Co-
morbidities included in our analysis were stroke, congestive
heart failure, myocardial infarction, ischemic heart disease,
and chronic kidney disease.
Because the risk of amputation in diabetic patients
varies according to patient-level comorbidities, beneficia-
ries were divided into low-risk and high-risk cohorts, using
Inpaent 
Claims 
Outpaent 
Claims 
SNF  
Claims 
Chronic 
Condion 
Summary File 
Beneﬁciary 
Summary File 
Hospice 
Claims 
Carrier 
Claims 
Diabetes 
Analyc 
File 
DME  
Claims HHA  
Claims 
Fig 1. Input files contributing to the Diabetes Analytical File
(DAF). DME, Durable medical equipment; HHA, home health
agencies; SNF, skilled nursing facility.previously published definitions of high-risk and low-risk Aopulations.11 The high-risk cohort was defined as those
ith end-stage renal disease (ESRD) or three or more
omorbidities (including diabetes), or both; whereas the
ow-risk cohort had three or fewer comorbidities and did
ot have a diagnosis of ESRD.
Analysis. Our main outcome measure was the ampu-
ation rate between 1999 and 2006. The Healthy People
010 initiative was implemented in 2000. Healthy People
010 used data from a variety of sources, including Na-
ional Hospital Discharge Survey, CDC, and National
ealth Interview Survey, to track amputation outcomes.
ccordingly, we examined secular trends in the amputation
ate during this period to assess the association between the
mplementation of Healthy People 2010 and population-
ased amputation rates. Dichotomous variables were ana-
yzed using 2 and continuous variables were analyzed
sing t-tests and analysis of variance. Data were analyzed
sing STATA 10 software (StataCorp, College Station,
ex).
ESULTS
Patient characteristics. Overall, we studied 4,943,398
edicare patients (mean age, 74 years) between 1999 and
006 (Table I) Women comprised 59.7% of all diabetic pa-
ients, and 12.7% of the diabetic patients were African Amer-
can. Overall, 8.2% of diabetic patients were high-risk, defined
s having a diagnosis of ESRD ormore than three comorbidi-
ies.
Incidence of amputation. There were 23,976 ampu-
ations over the course of the period studied, with an overall
mputation rate of 4.9/1000 diabetic patients (Table I).
mputees were slightly younger than those who did not
ndergo amputation (mean age, 73.4 vs 74; P  .001).
mong diabetic patients undergoing amputation, there
as an equal distribution of men and women (48% vs 52%).
able I. Demographic differences between Medicare
iabetic patients by amputation status
ariablea Amputationb No amputationb
otal number 23,976 (0.5) 4,919,422
ge
Mean years 73.4 74.0
50-64 4,571 (19) 509,932 (10)
65-74 7,958 (33) 2,077,317 (42)
75-84 7,961 (33) 1,732,289 (35)
84 3,486 (15) 599,884 (12)
emale 11,543 (48) 2,939,357 (59)
ace
White 16,317 (68) 3,954,265 (80)
Black 6,013 (25) 627,877 (13)
SRD 4,917 (21) 86,525 (2)
3 comorbidities 10,292 (43) 348,711 (7)
verall deaths during study
period 6,339 (26) 260,628 (5)
SRD, End-stage renal disease.
Data are shown as number (%) or as indicated.
P .001 calculated from 2 for all comparisons.s expected, diabetic patients who underwent amputation
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and to die than diabetic patients who did not undergo
amputation (Table I).
Differences over time. As outlined on its Web site
(www.healthypeople.gov/2010/), Healthy People 2010
established a goal of reducing amputation among diabetic
patients by 5.5% per year in the 10-year period between its
inception and 2010. However, during the early part of this
study period, the decline in amputation rate was much less
dramatic. Between 2000 and 2006, the overall rate of
Table II. Trends in characteristics of diabetic patients und
All
Variablea 1999 2006 P
Total number 3039 2549
Age
Mean, years 73.5 73.0 .0
50-64 16 22 .0
65-74 35 31 .0
75-84 34 33 .0
84 15 14 .8
Female 51 46 .0
Race
White 23 26 .0
Black 69 67 .0
ESRD 17 23 .0
3 comorbidities 33 50 .0
Overall deaths during study period 25 27 .1
ESRD, End-stage renal disease.
aData are shown as percentage, unless otherwise indicated.
b3 comorbidities (including diabetes), and did not have a diagnosis of ES
c3 comorbidities (including diabetes) or ESRD, or both.
dP calculated from 2 comparison.
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Fig 2. Temporal trends of amputations in diabetic ind
comorbidity status. ESRD, End-stage renal disease.amputation among all diabetic individuals declined by 0.6% 6er year (4.8/1000 in 2000 to 4.4/2006; P .001; Table
I; Fig 2). Rather than the goal proposed by Healthy
eople 2010 of a 38.5% decline, an 8% decline was achieved
uring the 8-year period.
During this interval, we noted two changes in our
opulation of Medicare patients with diabetes: First, dia-
etic patients undergoing amputation became younger.
he mean age of amputees decreased from 73.9 to 73.0
ears (P  .001). The decrease in mean age occurred
ecause the proportion of amputees who were aged 50 to
ing amputation over time, overall and by risk strata
betic patients undergoing amputations
High-riskb Low-riskc
1999 2006 Pd 1999 2006 Pd
1209 1389 1830 1160
71.7 72.2 .4 75.3 73.9 .001
24 24 .3 12 19 .001
35 30 .01 34 32 .03
30 33 .3 37 32 .001
10 12 .4 17 17 .7
51 46 .001 51 46 .001
26 30 .01 22 22 .6
66 63 .02 72 72 .9
45 43 .2 . . . . . . . . .
82 92 .001 . . . . . . . . .
36 34 .04 17 18 .3
2004 2005 2006
All amputations in Diabetics 
(8% decline, p<0.001)
4.4
3.7
2.2
1.2
1.0
Amputations in White Diabetics 
(12% decline, p<0.001)
Amputations in Diabetics with >3
comorbitidies
( 38% increase, p<0.001)
Amp. in African-American 
Diabetics 
(9% increase, p<0.02)
Amp. in Diabetics with ESRD 
(11% increase, p<0.001)
als (above-knee, below-knee, and minor), by race andergo
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decreased over time (34.8% to 30.8%; P  .001). The
second change was an increase in the proportion of high-
risk amputees over time. High-risk patients represented a
growing proportion of all amputations (33% in 1999, 50%
in 2006; P  .001), despite representing a minority of all
diabetic individuals (4% in 1999 to 10% in 2006; P .001).
Other smaller changes were evident over time as well.
Sex distribution changed significantly, with a smaller pro-
portion of amputations occurring in women (51% in 1999,
46% in 2006; P  .001). Although the amputation rate
among all African American beneficiaries decreased (9.2/
1000 in 1999 to 8.8/1000 in 2006; P  .021) the rate of
amputation in black patients remained significantly higher
than the rate of amputation in white beneficiaries (4.2/
1000 in 1999 and 3.7/1000 in 2006).
Differences in amputations between high-risk and
low-risk groups. Among all diabetic patients undergo-
ing amputation, 11,558 (48.2%) were high-risk, and
12,418 (51.8%) were low-risk (Table III). Although
representing almost half of all amputations, high-risk
patients represented only 7.3% of the entire population
with diabetes (Table I). Among high-risk amputees,
42.5% had ESRD, and 89.1% had more than three co-
morbidities. The high-risk cohort had a significantly
higher amputation rate than the low-risk cohort (28.6/
1000 vs 3.0./1000 diabetic individuals; P  .001).
Furthermore, compared with the low-risk amputee co-
hort, high-risk amputees were younger (mean age, 72.1
vs 74.6 years; P  .001), were more likely to be women
(48.6% vs 47.8%; P  .001), and a greater proportion
were African American (64% vs 22%; P  .001).
Effect of race and risk. Overall, the proportion of
African Americans was 25.1% in the amputee cohort vs
Table III. Characteristics among diabetic patients
undergoing amputation by risk strata
Variablea High-riskb Low-riskc
Total number 11,558 (48.2) 12,418 (51.8)
Mean age, years 72.1 74.6
50-64 2646 (22.9) 1925 (15.5)
65-74 3907 (33.8) 4051 (32.6)
75-84 3724 (32.2) 4237 (34.1)
84 1281 (11.1) 2205 (17.8)
Female 5611 (48.6) 5932 (47.8)
Race
White 3285 (28.4) 2728 (22.0)
Black 7397 (64.0) 8920 (71.8)
ESRD 4917 (42.5) . . .
3 comorbidities 10,292 (89.1) . . .
Overall deaths during
study period
4175 (36.1) 2164 (17.4)
ESRD, End-stage renal disease.
aData are shown as number (%), unless otherwise indicated.
b3 comorbidities (including diabetes), and did not have a diagnosis of
ESRD. P .001 calculated from 2 for all comparisons between groups.
c3 comorbidities (including diabetes) or ESRD, or both. P .001 calcu-
lated from 2 for all comparisons between groups.12.6% in nonamputee cohort (P .001). In both high-risk and low-risk diabetic cohorts, African Americans had
igher rates of amputations. The overall rate of amputa-
ions was 48.9/1000 among high-risk diabetic blacks vs
4.4/1000 among high-risk diabetic whites (P  .001). A
imilar difference existed in the low-risk cohorts, with an
mputation rate of 5.7/1000 in blacks and 2.6/1000 in
hites (P  .001; Fig 3).
ISCUSSION
This study sought to determine the effect of a national
iabetes quality initiative, Healthy People 2010, on ampu-
ation rates among Medicare diabetics. Our analysis of an
nhanced 5% sample of Medicare diabetic patients revealed
modest decrease, 8%, in the amputation rate over the
ourse of the period studied, with most of the decline
ccurring among white patients with diabetes. However,
mputation rates were significantly higher among African
mericans and high-risk patients such as those with ESRD
r multiple comorbidities. Although the average age of
mputees declined slightly, among high-risk patients, am-
utees tended to be older than their low-risk counterparts.
urthermore, over the course of the study, amputees had a
igher comorbidity burden. In 2000, Healthy People 2010
stablished a goal of decreasing the incidence of amputa-
ions among diabetic individuals from a baseline of 4.1/
000 in 2000 to 1.8/1000 in 2010, a 56% decline.4 Our
ata suggest that at the current rate of improvement, the
ate of decline in the rate of amputations will be insufficient
o achieve this goal. Some may question if the estimates
rom our enhanced Medicare data set (a 5% sample of all
edicare diabetics) are generalizable to the national pop-
lation of diabetic individuals; however, our estimates align
losely with those of the CDC andNIH, includingHealthy
eople 2020, a recently published revision of Healthy
eople 2010, in which the estimated 2010 amputation rate
mong diabetic individuals was 4/1000.5,12
Given these modest improvements in amputation rates
2.6
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ig 3. Amputation rate among Medicare diabetic patients by risk
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decline was not as large as anticipated, the rate of amputa-
tion among individuals with diabetes fell by 8%, andmost of
this decline was among white diabetic patients. Racial dis-
parity in diabetes care is not a new discovery.13 In the
setting of establishing preventive measures, our findings
highlight the need to focus specific efforts on traditional
underserved populations. Furthermore, the population of
amputees becamemore ill over the course of the study, with
a doubling of the number of amputees with more than
three comorbidities.
Before deciding whether this represents success or fail-
ure, one might consider these results in the context of
similar quality improvement efforts in limiting amputations
among diabetic individuals. Similar to Healthy People
2010, previously performed diabetes quality improvement
initiatives have also been associated with a variable degree
of success at reducing amputation rates. For example, anal-
ysis of U.S. Veterans Administration data, well-known for
its broad implementation of quality improvement mea-
sures, demonstrated a decline in amputation rate from
7/1000 patients to 4.6/1000 patients between 2000 and
2004.14
Second, analysis of all amputations among insulin-
dependent diabetic patients in the United Kingdom be-
tween 1996 and 2005 demonstrated an 11% decline.15
Therefore, although Healthy People 2010 did not reach
the ultimate goal of 1.8/1000 diabetic patients, the overall
outcomes (amputation rates and magnitude of change in
amputation rate over time) in Healthy People 2010 were
similar to the outcomes observed in other quality improve-
ment forums.
Our analysis suggests that to achieve progressive and
meaningful reduction in amputations among patients with
diabetes, quality initiatives need to focus on high-risk
groups and African Americans. Limiting amputation risk in
these groups will be difficult, however. Diabetic patients
undergoing amputation are now younger, with more bur-
den of comorbid illness. Disparities in care between African
American and white patients have a multitude of complex
associations involving several domains, including socioeco-
nomic status and access to care.16 Regardless of these
challenges, our data suggest that quality improvement ef-
forts need to further investigate and target their efforts on
these patients to maximize the reduction in amputation.
Our study has several limitations. First, because our
data set is based on administrative data, our ability to
perform risk adjustment by the severity of diabetes is lim-
ited. For instance, quantitative assessment of hemoglobin
A1c, insulin-dependence, and attempts at lower extremity
revascularization for those with underlying peripheral vas-
cular disease were not available and would have provided
further insight into the character and severity of disease.
Second, operation-specific details are lacking in the
database. Amputation was coded as a binomial variable,
without taking into account the level at which the extremity
was amputated, and certainly, an above-knee amputation
incurs markedly different disability than a minor forefoot oroe amputation. However, even minor amputations are
mportant in this context because any tissue loss in diabetic
atients is strongly associated with a further risk of future
mputation.17
Third, an important limitation of the applicability of
ur results to the general diabetic population is that not all
iabetic patients receive medical care in the Medicare sys-
em. The effect this subset of patients has on the popula-
ion-based assessment of amputation rates was not captured
n our analysis.
Lastly, because we used the last version of the enhanced
edicare data set, the most recent data within the database
re from 2006. Thus, analysis and inferences on more
ecent trends will necessitate a more recent composition of
nhanced Medicare data.
ONCLUSIONS
Amputation rates have modestly declined in Medicare
iabetic patients during a period of growing awareness and
ropagation of diabetes preventive care. However, signifi-
ant disparity remains among African Americans and those
ith a greater comorbidity burden. Future quality im-
rovement initiatives should focus on these groups to have
aximum preventive effect.
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